Morfološki i patohistološki nalaz na srcu obdukovanih korisnika heroina

  • Ivan Aleksić Vojnomedicinska akademija, Institut za patologiju i sudsku medicinu
  • Nadica Marinković Vojnomedicinska akademija, Institut za patologiju i sudsku medicinu
  • Jelena Džambas Vojnomedicinska akademija, Institut za patologiju i sudsku medicinu
Ključne reči: zavisnost od heroina;, srce;, miokard;, morfin;, histološke tehnike;, autopsija.

Sažetak


Uvod/Cilj. Heroin je polusintetska droga iz grupe opioida, koja može izazvati morfološke i patohistološke promene na srcu: hipertrofiju komora, fibrozu miokarda, hipertrofiju kardiomiocita, izvijuganost miofibrila, gubitak jedara i poprečne ispruganosti miocita, perivaskularna krvarenja i zapaljenski infiltrat. Cilj rada bio je da se prikažu morfološke i patohistološke promene kod obdukovanih osoba sa pozitivnim toksikološkim nalazom metabolita heroina: 6-monoacetilmorfina (6-MAM) i morfina. Metode. Retrospektivna studija je rađena u Institutu za patologiju i sudsku medicinu Vojnomedicinske akademije u Beogradu na 27 osoba starosti od 18 do 60 godina obdukovanih u periodu od 2010. do 2014. godine. Analizirani su debljina zida komora i patohistološki nalaz isečaka miokarda, obrađenih standardnom procedurom i obojenih hematoksilin-eozin (H&E) i trihromnim bojenjem (Masson). U uzorcima krvi i urina analizirane su koncentracije 6-MAM-a i morfina primenom tečne hromatografije sa detektorom visokih performansi sa fotodiodom (HPLC-PDA) ultravioletnim (UV) detektorom. Rezultati. Debljina zidova komora srca bila je kod 27/27 (100%) obdukovanih veća od normalne i to leva 1,74 ± 0,17 cm, a desna 0,6 ± 0,09 cm; fibroza miokarda kod 27/27 (100%) i to perivaskularna kod 24/27 (88,89%), a fokalna intersticijalna kod 3/27 (11,11%) obdukovanih; hipertrofija kardiomiocita kod 22/27 (81,48%); izvijuganost miofibrila kod 22/27 (81,48%); gubitak jedara i poprečne ispruganosti miocita kod 10/27 (37,04%); sveže perivaskularno krvarenje kod 23/27 (85,19%); fokalni zapaljenski infiltrat kod 14/27 (51,85%). Toksikološkom analizom kod 27/27 (100%) obdukovanih su nađeni 6-MAM i morfin u urinu. Zajedno u krvi nađeni su 6-MAM i morfin kod 3/27 (11,11%), a samo morfin kod 16/27 (59,26%) obdukovanih. Zaključak. Našim istraživanjem utvrđene su morfološke (hipertrofija leve i desne komore srca) i patohistološke promene (fibroza miokarda, hipertrofija kardiomiocita, izvijuganost miofibrila, gubitak jedara i poprečne ispruganosti miocita, sveže perivaskularno krvarenje, fokalni inflamatorni infiltrat) kod obdukovanih heroinomana. Te promene su nespecifične i mogu biti uslovljene dugotrajnom upotrebom heroina, ali i nizom drugih faktora. Zbog nedostatka medicinske dokumentcije ispitanika ne možemo isključiti mo­gućnost da ostali faktori, pored dugotrajne upotrebe heroina, mogu biti uzrok opisanih promena na srcu.

Reference

Seltenhammer HM, Marchar K, Paula P, Kordina N, Klupp N, Schnei¬der B, et al. Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse. Addiction 2013; 108(7): 1287–95.

Karch BS. Drug Abuse Handbook. 3rd ed. Boca Raton: CRC press; 1998; 20–4, 119–20, 400.

Yamada H, Ishii J, Oguri K. Metabolism of drugs of abuse: its contribution to the toxicity and the inter-individual differ-ences in drug sensitivity. J Health Sci 2005; 51(1): 1–7.

Fujimoto JM, Way EL. Isolation and crystallization of “blood” morphine from urine of human addicts. J Pharmacol Exp Ther 1957; 121(3): 340–6.

O’Neal CL, Poklis A. The detection of acetyl codeine and 6-ace¬tylmorphine in opiate positive urines. Forensic Sci Int 1998; 95(1): 1–10.

Tasic M. Forensic medicine. 1st ed. Novi Sad: Zmaj; 2006. (Ser¬bian)

Darke S, Kaye S, Duflou J. Systemic disease among cases of fatal opioid toxicity. Addiction 2006; 101(9): 1299–305.

Dettmeyer R, Friedrich K, Schmidt P, Madea B. Heroin-associated myocardial damages-conventional and immunohistochemical investigations. Forensic Sci Int 2009; 187(1–3): 42–6.

Ludwig J. Handbook of autopsy practice. 3rd ed. Totowa, New Jersey: Humana Press; 2002.

Benomran F. Post-mortem sole incisions – A new sign of heroin overdose? J Forensic Leg Med 2008; 15(1): 50–63.

Hennings C, Miller J. Illict drugs: What dermatologists need to know. J Am Acad Dermatol 2013; 69(1): 135–42.

Rajs J, Falconer B. Cardiac lesions in intravenous drug addicts. Forensic Sci Int 1979; 13(3): 193–209.

Kumar V, Abbas A, Fausto N, Aster CJ. Pathologic basis of dis-ease. 8th ed. Philadelphia: Saunders Elsevier; 2010.

Tanajak P, Chattipakorn SC, Chattipakorn N. Effects of fibro-blast growth factor 21 on the heart. J Endocrinol 2015; 227(2): R13–30.

Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 2002; 91(12): 1103–13.

Darke S, Duflou J, Torok M. The comparative toxicology and ma¬jor organ pathology of fatal methadone and heroin toxicity cases. Drug Alcohol Depend 2010; 106(1): 1–6.

Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, et al. The effects of heroin in catecholamine me-tabolism in men. Natl Inst Drug Abuse Res Monogr Ser 1975; 3: 137–45.

Katchorchis T, Bourdenas P, Mouzaki D, Bei-Paraskevopouolu T, Vam¬vakopouolus N. Heroin-induced changes of catecholamine-containing particles in male rat cerebellar cortex. Life Sciences 2001; 69(3): 347–58.

Srettabunjong S. A fatal heroin addict with myocardial lesion. J Med Assoc Thai 2009; 92(2): 279–83.

Paterna S, Di Pasquale P, Montaina G, Procaccianti P, Antona A, Scaglione R, et al. Effect of heroin and morphine on cardiac performance in isolated and perfused rabbit heart: evaluation of cardiac haemodynamics, myocardial enzyme activity and ul-trastructure features. Cardiologia 1991; 36(10): 811–5.

Schwartzfarb L, Singh G, Marcus D. Heroin associated rhabdo-myolysis with cardiac involvement. Arch Intern Med 1977; 137(9): 1255–7.

Melandri R, De Tommaso I, Zele I, Rizzoli D, Rapezzi C, Pezzilli R, et al. Myocardial involvement in rhabdomyolysis caused by acute heroin intoxication. Recenti Prog Med 1991; 82(6): 324–7. (Italian)

Sztajzel J, Karpuz H, Rutishauser W. Heroin abuse and myocar-dial infarction. Int J Cardiol 1994; 47(2): 180–2.

Schwartz RH. Adolescent heroin use: a review. Paediatrics 1998; 102(6): 1461–6.

Suematsu M, Ito Y, Fukuzaki H. The role of parasympathetic nerve activity in the pathogenesis of coronary vasospasm. Jpn Heart J 1987; 28(5): 649–61.

Bartolomei F, Nicoli F, Swiader L, Gastaut JL. Ischaemic cerebral vascular stroke after heroin sniffing. A new case. Press Med 1992; 21(21): 893–6. (French)

Objavljeno
2021/01/13
Rubrika
Originalni članak